Home › The New Strategic CDMO: End-to-End Solutions for Better and Faster Drug Development
 

Keywords :   


The New Strategic CDMO: End-to-End Solutions for Better and Faster Drug Development

2016-05-17 11:52:14| drugdiscoveryonline News Articles

While Big Pharma historically has kept development activities and CMC management in-house, unpredictable pipelines and increasing drug complexity have compelled the industry to look more seriously at outsourcing drug development and manufacturing to increase productivity and throughput. Bill Weiser, the executive director and global head of analytical sciences at Patheon, discusses how a new generation of CDMOs have positioned themselves to provide more strategic solutions that not only complement product development but also drive therapies to patients faster.

Tags: development solutions drug faster

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.10Hurricane Milton Forecast Discussion Number 12
08.10Hurricane Milton Wind Speed Probabilities Number 12
08.10Hurricane Milton Forecast Advisory Number 12
08.10Hurricane Milton Public Advisory Number 12
08.10Summary for Hurricane Milton (AT4/AL142024)
08.10Hurricane Leslie Wind Speed Probabilities Number 23
08.10Hurricane Leslie Public Advisory Number 23
08.10Summary for Hurricane Leslie (AT3/AL132024)
More »